Group 1 Group 2 p Value
ASA 1-2 29 (80.6%) 13 (46.4%) 0.004
ASA 3 7 (19.4%) 15 (53.6%)
Comorbidity Present Absent 17 (47.2%) 17 /47.2%) 7 (25%) 21 (75%)
0.025
Preoperative Hospitalization period, day Comorbidity present Comorbidity absent 3.9±2.6 6.1±4.0 5.9±2.5 9.8±4.2 0.047 0.008
Surgery Duration (min) (mean±SD) 125.4±29.5 148.9±39.9 0.018
Hematocrit (n, %) <30 >30 16 (44,4%) 20 (55,6%) 21 (75%) 7 (25%)
0.014
Atropine (n, %) Administered Not administered 34 (94.4%) 2 (5.6%) 26 (92.9%) 2 (7.1%)
>0.999
Ephedrine (n, %) Administered Not administered 33 (91.7%) 3 (8.3%) 15 (53.6%) 13 (46.4%)
<0.001
Midazolam (n, %) Administered Not administered 19 (52.8%) 17 (47.2%) 19 (67.9%) 9 (32.1%)
0.223
Crystalloid (ml) (Mean±SD) 2222±806 1821±495 0.087
Colloid Replacement (n, %) Administered Not administered 21 (58.3%) 15 (41.7%) 18 (64.3%) 10 (35.7%)
0.628
Hemorrhage (ml) (Mean±SD) 633.3±305.9 764.3±322.3 0.046
Erythrocyte Replacement (n, %) Administered Not administered 21 (58.3%) 15 (41.7%) 19 (67.9%) 9 (32.1%)
0.892